FDA Leadership Shakeup: New Faces on the Horizon
The acting chief of the U. S. Food and Drug Administration’s drug center, Tracey Beth Hoeg, is likely to step down shortly after the resignation of Commissioner Marty Makary, according to insiders familiar with agency plans. Hoeg, a former epidemiologist and sports doctor known for questioning COVID